Posted by Michael Wonder on 19 Aug 2022
1 September 2022 updates as part of the digital transformation of authority required (written) PBS listings
19 August 2022 - From 1 September 2022, the PBS listings for certain cancer medicines will be updated as part of the Department of Health and Aged Care’s digital transformation of authority required (written) PBS listings.
Real time assessment of authority requests for these medicines will be available through Services Australia’s Online PBS Authorities system, via Health Professional Online Services.
From 1 September 2022, the PBS listings for the following cancer medicines will be updated:
- Brentuximab vedotin
- Crizotinib
- Entrectinib
- Lenalidomide
- Pomalidomide
- Pembrolizumab
- Ruxolitinib phosphate
- Sonidegib diphosphate
- Vismodegib
- Sunitinib maleate
- Vorinostat
